









Mercados
/
Ações
/
nasdaq-arct
/

Arcturus Therapeutics Holdings Inc

ARCT

8.041USD

-0.249-3.01%

Horário de mercado （ET）Cotações atrasadas em 15 min

218.29MValor de mercado

PerdaP/L TTM



Arcturus Therapeutics Holdings Inc

8.041

-0.249-3.01%

Visão Geral Empresa Serviços Financeiros Análises

Visão Geral

Empresa

Serviços Financeiros

Análises

Mais detalhes de Arcturus Therapeutics Holdings Inc Empresa

Arcturus Therapeutics Holdings Inc. is a global messenger RNA medicines and vaccine company. The Company is focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. In addition to its messenger RNA (mRNA) platform, its lipid nanoparticle (LNP) delivery system, LUNAR, has the potential to enable multiple nucleic acid medicines, and its self-amplifying mRNA technology (Self-Transcribing and Replicating RNA (STARR), technology) has the potential to provide longer-lasting RNA and sustained protein expression at lower dose level. It is leveraging its LUNAR platform and its nucleic acid technologies to develop and advance a pipeline of mRNA-based vaccines and therapeutics for infectious diseases and rare genetic disorders with significant unmet medical needs. Its COVID-19 vaccine candidate, which is based on its STARR technology platform is through Phase II clinical trials.

Informações de Arcturus Therapeutics Holdings Inc



Código da empresaARCT

Nome da EmpresaArcturus Therapeutics Holdings Inc

Data de listagemMay 22, 2013

CEOMr. Joseph E. Payne

Número de funcionários174

Tipo de títulosOrdinary Share

Fim do ano fiscalMay 22

Endereço10628 Science Center Dr Ste 250

CidadeSAN DIEGO

Bolsa de valoresNASDAQ Global Market Consolidated

PaísUnited States of America

Código postal92121-1132

Telefone18589002660

Sitehttps://arcturusrx.com/

Código da empresaARCT

Data de listagemMay 22, 2013

CEOMr. Joseph E. Payne

Executivos da empresa Arcturus Therapeutics Holdings Inc



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Joseph E. Payne

President, Chief Executive Officer, Director

1.48M

Dr. Padmanabh Chivukula

Chief Operating Officer, Chief Scientific Officer

435.33K

Mr. Lance Kurata

Chief Legal Officer

Dr. Adm. Jing L. Marantz, M.D., Ph.D.

Independent Director

Dr. Edward W. Holmes, M.D.

Independent Director

Mr. James F. Barlow

Independent Director

Dr. John H. Markels, Ph.D.

Independent Director

Dr. Magda Marquet, Ph.D.

Independent Director

-100.00%

Mr. Andrew H. (Andy) Sassine

Chief Financial Officer, Director

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Joseph E. Payne

President, Chief Executive Officer, Director

1.48M

Dr. Padmanabh Chivukula

Chief Operating Officer, Chief Scientific Officer

435.33K

Mr. Lance Kurata

Chief Legal Officer

Dr. Adm. Jing L. Marantz, M.D., Ph.D.

Independent Director

Dr. Edward W. Holmes, M.D.

Independent Director

Mr. James F. Barlow

Independent Director

Detalhamento da receita

Sem dados

Sem dados

Por Empresa

Por Região

Sem dados

Distribuição de ações

Atualizado em: sáb, 16 de ago

Investidores

Tipos de investidores

Investidores

Proporção

Federated Hermes Global Investment Management Corp.

17.29%

BlackRock Institutional Trust Company, N.A.

7.90%

Amova Asset Management Co., Ltd.

7.17%

The Vanguard Group, Inc.

6.67%

ARK Investment Management LLC

6.32%

Outro

54.66%

Investidores

Proporção

Federated Hermes Global Investment Management Corp.

17.29%

BlackRock Institutional Trust Company, N.A.

7.90%

Amova Asset Management Co., Ltd.

7.17%

The Vanguard Group, Inc.

6.67%

ARK Investment Management LLC

6.32%

Outro

54.66%

Tipos de investidores

Investidores

Proporção

Investment Advisor/Hedge Fund

42.37%

Investment Advisor

27.91%

Hedge Fund

12.32%

Individual Investor

7.87%

Research Firm

5.52%

Insurance Company

1.01%

Pension Fund

0.52%

Bank and Trust

0.14%

Outro

2.34%

Participação acionária institucional



Atualizado em: qua, 1 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

379

24.38M

89.79%

-4.19M

2025Q2

391

26.78M

98.75%

-3.73M

2025Q1

403

27.75M

102.37%

-3.11M

2024Q4

400

27.43M

101.26%

-2.26M

2024Q3

404

26.95M

99.66%

-3.33M

2024Q2

409

27.79M

102.77%

-2.68M

2024Q1

391

28.99M

107.82%

+144.88K

2023Q4

376

27.09M

101.05%

-1.26M

2023Q3

373

26.77M

100.23%

-170.02K

2023Q2

355

26.49M

99.74%

-2.09M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

Federated Hermes Global Investment Management Corp.

4.69M

17.29%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

2.14M

7.9%

+24.09K

+1.14%

Jun 30, 2025

Amova Asset Management Co., Ltd.

1.83M

6.75%

-93.62K

-4.86%

Jun 30, 2025

The Vanguard Group, Inc.

1.81M

6.67%

+66.51K

+3.81%

Jun 30, 2025

ARK Investment Management LLC

1.72M

6.32%

-293.44K

-14.61%

Jun 30, 2025

Payne (Joseph E)

1.48M

5.45%

Apr 08, 2025

State Street Investment Management (US)

1.02M

3.76%

-260.68K

-20.36%

Jun 30, 2025

Balyasny Asset Management LP

864.10K

3.18%

-74.09K

-7.90%

Jun 30, 2025

Schonfeld Strategic Advisors LLC

784.41K

2.89%

-41.36K

-5.01%

Jun 30, 2025

Woodline Partners LP

780.44K

2.87%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: qui, 6 de nov

Nome

Proporção

ARK Genomic Revolution ETF

3.02%

WisdomTree BioRevolution Fund

2.13%

Virtus LifeSci Biotech Clinical Trials ETF

1.05%

iShares Genomics Immunology and Healthcare ETF

1.03%

AXS Green Alpha ETF

0.65%

Global X Genomics & Biotechnology ETF

0.52%

ALPS Medical Breakthroughs ETF

0.3%

SPDR S&P Biotech ETF

0.17%

iShares Micro-Cap ETF

0.09%

Direxion Daily S&P Biotech Bull 3X Shares

0.09%

Ver Mais

ARK Genomic Revolution ETF

Proporção3.02%

WisdomTree BioRevolution Fund

Proporção2.13%

Virtus LifeSci Biotech Clinical Trials ETF

Proporção1.05%

iShares Genomics Immunology and Healthcare ETF

Proporção1.03%

AXS Green Alpha ETF

Proporção0.65%

Global X Genomics & Biotechnology ETF

Proporção0.52%

ALPS Medical Breakthroughs ETF

Proporção0.3%

SPDR S&P Biotech ETF

Proporção0.17%

iShares Micro-Cap ETF

Proporção0.09%

Direxion Daily S&P Biotech Bull 3X Shares

Proporção0.09%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

KeyAI

